尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Crane Rosemary A, 董事. Insider active across 4 companies, notably Teva Pharmaceutical Industries Ltd. Cumulatively, 16 reports have been logged. Activity tracked since 28 October 2021. The latest transaction was filed on 14 May 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 条申报中的 16 条
Crane Rosemary A is Administrateur and has filed 16 disclosures in total. In the 16 sampled disclosures, the most frequent transaction nature is option exercise, with dates ranging from 2021-06-08 to 2026-06-08. Filings were reported for Teva Pharmaceutical Industries Ltd, Certara, Inc., Catalent, Inc. and Tarsus Pharmaceuticals, Inc.